Get startedLog in
    Picture of Amniotics AB (publ) logo

    AMNI — Amniotics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Amniotics Receives U.S. Patent For Its Oncology Program AMNI-NK003

    Picture of Amniotics AB (publ) logoAmniotics AB (publ)
    25/10/2022 10:28
    Oct 25 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * AMNIOTICS GRANTED U.S. PATENT FOR ITS ONCOLOGY PROGRAM
AMNI-NK003
    * US PATENT AND TRADEMARK OFFICE (USPTO) HAS APPROVED A
PATENT
APPLICATION THAT SUPPORTS COMPANY'S ANTI-CANCER PLATFORM
AMNI-NK003

Source text for Eikon:  ID:nMFN2pZN7R 
Further company coverage:  AMNI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Amniotics AB (publ)

    See all news